Current Environment: Production

Recall Alert

There is an antibacterial antibiotic recall. Read more →
X

CLAIM YOUR MATCH

Your gift, now MATCHED, will help save lives today — and for generations to come.

DONATE NOW

Education

Undergraduate School

City College of New York

1973, New York, NY

Medical School

New York Medical College

1976, Valhalla, NY

Residency

New York Medical College

1978, New York, NY

Fellowship

NY Hospital-Cornell Medical Center

1980, New York, NY

Education

Undergraduate School

University of Wisconsin

1994, Madison, WI

Medical School

Sackler School of Medicine

1999, Tel Aviv, Israel

Internship

Mount Sinai School of Medicine

2000, New York, NY

Residency

Mount Sinai School of Medicine

2002, New York, NY

Education

Medical School

Westfalische Wilhelms-Universitat

1999, Munster, Germany

Internship

Pediatrics

Cleveland Clinic

2004, Cleveland, OH

Residency

Neurology

Westfalische Wilhelms-Universitat

Munster, Germany

Residency

Pediatrics

Cleveland Clinic

Cleveland, OH

Residency

Child Neurology

Cleveland Clinic

2008, Cleveland, OH

Fellowship

Epilepsy & Clinical Neurophysiology

Cleveland Clinic

2003, Cleveland, OH

Publications

  1. Time to treatment in pediatric patients with repeated episodes of status epilepticus. BMC Neurol. 2025 May 26; 25(1):221. View Abstract

  2. Prioritising faster, individualised rescue treatment in status epilepticus - Authors' reply. Lancet Neurol. 2025 May; 24(5):382-383. View Abstract

  3. Assessment of Seizure Action Plans in Pediatric Convulsive Status Epilepticus: Focus on Benzodiazepine-Responsive and Resistant Cases. Neurol Clin Pract. 2025 Jun; 15(3):e200449. View Abstract

  4. Validation of a discrete electrographic seizure detection algorithm for extended-duration, reduced-channel wearable EEG. Epilepsia. 2025 Mar 19. View Abstract

  5. Treating seizures faster: The Quality Improvement in Time to Treat Status Epilepticus (QuITT-SE) multicenter randomized stepped wedge clinical trial protocol. Contemp Clin Trials. 2025 Apr; 151:107831. View Abstract

  6. Utilizing natural language processing to identify pediatric patients experiencing status epilepticus. Seizure. 2025 Feb; 125:54-61. View Abstract

  7. Improving the health literacy of persons with epilepsy. Epilepsy Behav. 2025 Feb; 163:110237. View Abstract

  8. Diagnosis and management of status epilepticus: improving the status quo. Lancet Neurol. 2025 Jan; 24(1):65-76. View Abstract

  9. Lack of association of first and second-line medication dosing and progression to refractory status epilepticus in children. Seizure. 2024 Dec; 123:133-141. View Abstract

  10. Effects of epileptic seizures on the quality of biosignals recorded from wearables. Epilepsia. 2024 Dec; 65(12):3513-3525. View Abstract

  11. Autonomic biosignals, seizure detection, and forecasting. Epilepsia. 2024 Jun 05. View Abstract

  12. Veni, Vidi, Vici-When Is Home Video Seizure Monitoring Helpful? Epilepsy Curr. 2025 Jan-Feb; 25(1):9-16. View Abstract

  13. Minimum clinical utility standards for wearable seizure detectors: A simulation study. Epilepsia. 2024 Apr; 65(4):1017-1028. View Abstract

  14. Ultradian rhythms in accelerometric and autonomic data vary based on seizure occurrence in paediatric epilepsy patients. Brain Commun. 2024; 6(2):fcae034. View Abstract

  15. Biologic Correlates and Consequences of the Social Determinants of Health and Disease. Perspect Biol Med. 2024; 67(3):305-324. View Abstract

  16. Review on the current long-term, limited lead electroencephalograms. Epilepsy Behav. 2024 Jan; 150:109557. View Abstract

  17. Design, implementation, and inferential issues associated with clinical trials that rely on data in electronic medical records: a narrative review. BMC Med Res Methodol. 2023 11 16; 23(1):271. View Abstract

  18. Biases in Electronic Health Records Data for Generating Real-World Evidence: An Overview. J Healthc Inform Res. 2024 Mar; 8(1):121-139. View Abstract

  19. Artificial intelligence-enhanced epileptic seizure detection by wearables. Epilepsia. 2023 Dec; 64(12):3213-3226. View Abstract

  20. Natural language processing for identification of refractory status epilepticus in children. Epilepsia. 2023 Dec; 64(12):3227-3237. View Abstract

  21. Development of a Multivariable Seizure Likelihood Assessment Based on Clinical Information and Short Autonomic Activity Recordings for Children With Epilepsy. Pediatr Neurol. 2023 Nov; 148:118-127. View Abstract

  22. Pediatric status epilepticus management by Emergency Medical Services (the pSERG cohort). Seizure. 2023 Oct; 111:51-55. View Abstract

  23. Early Clinical Variables Associated With Refractory Convulsive Status Epilepticus in Children. Neurology. 2023 08 01; 101(5):e546-e557. View Abstract

  24. Explainable AI for wearable seizure logging: Impact of data quality, patient age, and antiseizure medication on performance. Seizure. 2023 Aug; 110:99-108. View Abstract

  25. Self-management education for children with epilepsy and their caregivers. A scoping review. Epilepsy Behav. 2023 Jul; 144:109232. View Abstract

  26. Creation of a Novel Child Simulator and Curriculum to Optimize Administration of Seizure Rescue Medication. Simul Healthc. 2024 Oct 01; 19(5):326-332. View Abstract

  27. Survey of Pediatric ICU EEG Monitoring-Reassessment After a Decade. J Clin Neurophysiol. 2024 Jul 01; 41(5):458-472. View Abstract

  28. Detect, predict, and prevent acute seizures and status epilepticus. Epilepsy Behav. 2023 04; 141:109141. View Abstract

  29. Systemic inflammation as a biomarker of seizure propensity and a target for treatment to reduce seizure propensity. Epilepsia Open. 2023 03; 8(1):221-234. View Abstract

  30. Data quality evaluation in wearable monitoring. Sci Rep. 2022 Dec 10; 12(1):21412. View Abstract

  31. Challenges for Emergency Medical Services in Status Epilepticus Management. Pediatr Neurol. 2023 01; 138:5-6. View Abstract

  32. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications. Brain. 2022 09 14; 145(9):2991-3009. View Abstract

  33. Prevalence and Predictors of Seizure Clusters in Pediatric Patients With Epilepsy: The Harvard-Yale Pediatric Seizure Cluster Study. Pediatr Neurol. 2022 12; 137:22-29. View Abstract

  34. Seizure-related differences in biosignal 24-h modulation patterns. Sci Rep. 2022 09 05; 12(1):15070. View Abstract

  35. Measuring Real-Time Medication Effects From Electroencephalography. J Clin Neurophysiol. 2024 Jan 01; 41(1):72-82. View Abstract

  36. Inequities in Therapy for Infantile Spasms: A Call to Action. Ann Neurol. 2022 07; 92(1):32-44. View Abstract

  37. Identifying Barriers to Care in the Pediatric Acute Seizure Care Pathway. Int J Integr Care. 2022 Jan-Mar; 22(1):28. View Abstract

  38. Wearable device assessments of antiseizure medication effects on diurnal patterns of electrodermal activity, heart rate, and heart rate variability. Epilepsy Behav. 2022 04; 129:108635. View Abstract

  39. Coarse-graining and the Haar wavelet transform for multiscale analysis. Bioelectron Med. 2022 Feb 02; 8(1):3. View Abstract

  40. Super-Refractory Status Epilepticus in Children: A Retrospective Cohort Study. Pediatr Crit Care Med. 2021 12 01; 22(12):e613-e625. View Abstract

  41. Generalized tonic-clonic seizures are accompanied by changes of interrelations within the autonomic nervous system. Epilepsy Behav. 2021 Oct 05; 124:108321. View Abstract

  42. Genomic analysis of "microphenotypes" in epilepsy. Am J Med Genet A. 2022 01; 188(1):138-146. View Abstract

  43. Comparative Effectiveness of Initial Treatment for Infantile Spasms in a Contemporary US Cohort. Neurology. 2021 Sep 20; 97(12):e1217-e1228. View Abstract

  44. Wearable devices for seizure detection: Practical experiences and recommendations from the Wearables for Epilepsy And Research (WEAR) International Study Group. Epilepsia. 2021 10; 62(10):2307-2321. View Abstract

  45. Benzodiazepine administration patterns before escalation to second-line medications in pediatric refractory convulsive status epilepticus. Epilepsia. 2021 11; 62(11):2766-2777. View Abstract

  46. Prospective Study of a Multimodal Convulsive Seizure Detection Wearable System on Pediatric and Adult Patients in the Epilepsy Monitoring Unit. Front Neurol. 2021; 12:724904. View Abstract

  47. Association between semiologic, autonomic, and electrographic seizure characteristics in children with generalized tonic-clonic seizures. Epilepsy Behav. 2021 09; 122:108228. View Abstract

  48. EEG Biomarkers of Repository Corticotropin Injection Treatment. J Clin Neurophysiol. 2023 Mar 01; 40(3):236-243. View Abstract

  49. Video-Based Detection of Generalized Tonic-Clonic Seizures Using Deep Learning. IEEE J Biomed Health Inform. 2021 08; 25(8):2997-3008. View Abstract

  50. Seizure detection using wearable sensors and machine learning: Setting a benchmark. Epilepsia. 2021 08; 62(8):1807-1819. View Abstract

  51. Factors associated with long-term outcomes in pediatric refractory status epilepticus. Epilepsia. 2021 09; 62(9):2190-2204. View Abstract

  52. Measuring the effects of sleep on epileptogenicity with multifrequency entropy. Clin Neurophysiol. 2021 09; 132(9):2012-2018. View Abstract

  53. Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort). Epilepsia. 2021 07; 62(7):1629-1642. View Abstract

  54. Prediction of Seizure Recurrence. A Note of Caution. Front Neurol. 2021; 12:675728. View Abstract

  55. Time to Treatment in Pediatric Convulsive Refractory Status Epilepticus: The Weekend Effect. Pediatr Neurol. 2021 07; 120:71-79. View Abstract

  56. Author Response: Association of Guideline Publication and Delays to Treatment in Pediatric Status Epilepticus. Neurology. 2021 03 09; 96(10):503. View Abstract

  57. Evaluation and recommendations for effective data visualization for seizure forecasting algorithms. JAMIA Open. 2021 Jan; 4(1):ooab009. View Abstract

  58. Twenty-four-hour patterns in electrodermal activity recordings of patients with and without epileptic seizures. Epilepsia. 2021 04; 62(4):960-972. View Abstract

  59. Efficacy and Tolerability of Rufinamide in Epileptic Children Younger Than 4 Years. J Child Neurol. 2021 03; 36(4):281-287. View Abstract

  60. Status Epilepticus-Work-Up and Management in Children. Semin Neurol. 2020 12; 40(6):661-674. View Abstract

  61. Machine learning from wristband sensor data for wearable, noninvasive seizure forecasting. Epilepsia. 2020 12; 61(12):2653-2666. View Abstract

  62. The burden of decisional uncertainty in the treatment of status epilepticus. Epilepsia. 2020 10; 61(10):2150-2162. View Abstract

  63. First-line medication dosing in pediatric refractory status epilepticus. Neurology. 2020 11 10; 95(19):e2683-e2696. View Abstract

  64. Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee. Epilepsy Curr. 2020 Sep; 20(5):245-264. View Abstract

  65. Photoplethysmography: A measure for the function of the autonomic nervous system in focal impaired awareness seizures. Epilepsia. 2020 08; 61(8):1617-1626. View Abstract

  66. Retrospective observational study on hospital readmission for status epilepticus in the United States over 2016. Epilepsia. 2020 07; 61(7):1386-1396. View Abstract

  67. Autonomic nervous system changes detected with peripheral sensors in the setting of epileptic seizures. Sci Rep. 2020 07 14; 10(1):11560. View Abstract

  68. Photoplethysmographic evaluation of generalized tonic-clonic seizures. Epilepsia. 2020 08; 61(8):1606-1616. View Abstract

  69. EEG features of brain injury during extracorporeal membrane oxygenation in children. Neurology. 2020 09 08; 95(10):e1372-e1380. View Abstract

  70. Slow wave activity during NREM sleep in patients with electrical status epilepticus in sleep. Seizure. 2020 08; 80:257-258. View Abstract

  71. Association of guideline publication and delays to treatment in pediatric status epilepticus. Neurology. 2020 09 01; 95(9):e1222-e1235. View Abstract

  72. Nonlinear Analysis of Visually Normal EEGs to Differentiate Benign Childhood Epilepsy with Centrotemporal Spikes (BECTS). Sci Rep. 2020 05 21; 10(1):8419. View Abstract

  73. Mortality in infantile spasms: A hospital-based study. Epilepsia. 2020 04; 61(4):702-713. View Abstract

  74. Electrocardiographic changes associated with epilepsy beyond heart rate and their utilization in future seizure detection and forecasting methods. Clin Neurophysiol. 2020 04; 131(4):866-879. View Abstract

  75. Pharmacotherapy for Pediatric Convulsive Status Epilepticus. CNS Drugs. 2020 01; 34(1):47-63. View Abstract

  76. Seizure prediction and intervention. Neuropharmacology. 2020 08 01; 172:107898. View Abstract

  77. Novel treatment approaches and pediatric research networks in status epilepticus. Epilepsy Behav. 2019 12; 101(Pt B):106564. View Abstract

  78. Estimating the cost of status epilepticus admissions in the United States of America using ICD-10 codes. Seizure. 2019 Oct; 71:295-303. View Abstract

  79. Electroencephalographic Reporting for Refractory Status Epilepticus. J Clin Neurophysiol. 2019 Sep; 36(5):365-370. View Abstract

  80. Bone Health Screening Practices Among Neurologists in Patients on Antiepileptic Drugs: A Quality Improvement Project. Pediatr Neurol. 2020 01; 102:49-55. View Abstract

  81. The onset of pediatric refractory status epilepticus is not distributed uniformly during the day. Seizure. 2019 Aug; 70:90-96. View Abstract

  82. Immediate outcomes in early life epilepsy: A contemporary account. Epilepsy Behav. 2019 08; 97:44-50. View Abstract

  83. Encephalopathy with continuous spike-waves during slow-wave sleep: evolution and prognosis. Epileptic Disord. 2019 Jun 01; 21(S1):15-21. View Abstract

  84. Encephalopathy related to Status Epilepticus during slow Sleep: from concepts to terminology. Epileptic Disord. 2019 Jun 01; 21(S1):5-12. View Abstract

  85. Automated detection of sudden unexpected death in epilepsy risk factors in electronic medical records using natural language processing. Epilepsia. 2019 06; 60(6):1209-1220. View Abstract

  86. Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus. Neurology. 2019 05 14; 92(20):e2339-e2348. View Abstract

  87. Peripheral multimodal monitoring of ANS changes related to epilepsy. Epilepsy Behav. 2019 07; 96:69-79. View Abstract

  88. Seizure Prediction Models in the Neonatal Intensive Care Unit. J Clin Neurophysiol. 2019 May; 36(3):186-194. View Abstract

  89. Characteristics of Future Models of Integrated Outpatient Care. Healthcare (Basel). 2019 Apr 27; 7(2). View Abstract

  90. New onset refractory status epilepticus research: What is on the horizon? Neurology. 2019 04 23; 92(17):802-810. View Abstract

  91. Outcome of ambulatory video-EEG monitoring in a ˜10,000 patient nationwide cohort. Seizure. 2019 Mar; 66:104-111. View Abstract

  92. Timely Interventions for Children with ADHD through Web-Based Monitoring Algorithms. Diseases. 2019 Feb 07; 7(1). View Abstract

  93. Using EHRs to advance epilepsy care. Neurol Clin Pract. 2019 Feb; 9(1):83-88. View Abstract

  94. Diagnostic yield of genetic tests in epilepsy: A meta-analysis and cost-effectiveness study. Neurology. 2019 Jan 28; 92(5):e418-e428. View Abstract

  95. Chronotherapeutic implications of cyclic seizure patterns. Nat Rev Neurol. 2018 Dec; 14(12):696-697. View Abstract

  96. KCTD7 deficiency defines a distinct neurodegenerative disorder with a conserved autophagy-lysosome defect. Ann Neurol. 2018 11; 84(5):766-780. View Abstract

  97. Circadian rhythm and epilepsy. Lancet Neurol. 2018 12; 17(12):1098-1108. View Abstract

  98. Status epilepticus prevention, ambulatory monitoring, early seizure detection and prediction in at-risk patients. Seizure. 2019 May; 68:31-37. View Abstract

  99. Caring electronically for young outpatients who have epilepsy. Epilepsy Behav. 2018 10; 87:226-232. View Abstract

  100. Long-term outcomes of status epilepticus: A critical assessment. Epilepsia. 2018 10; 59 Suppl 2:155-169. View Abstract

  101. Estimating the cost of admissions related to convulsive status epilepticus in the United States of America. Seizure. 2018 Oct; 61:186-198. View Abstract

  102. Neuroimaging of Early Life Epilepsy. Pediatrics. 2018 09; 142(3). View Abstract

  103. Hospital Emergency Treatment of Convulsive Status Epilepticus: Comparison of Pathways From Ten Pediatric Research Centers. Pediatr Neurol. 2018 09; 86:33-41. View Abstract

  104. Automating Interictal Spike Detection: Revisiting A Simple Threshold Rule. Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul; 2018:299-302. View Abstract

  105. Timing in the treatment of status epilepticus: From basics to the clinic. Seizure. 2019 May; 68:22-30. View Abstract

  106. Machine Learning for Outcome Prediction in Electroencephalograph (EEG)-Monitored Children in the Intensive Care Unit. J Child Neurol. 2018 07; 33(8):546-553. View Abstract

  107. Efficacy and safety of ketogenic diet for treatment of pediatric convulsive refractory status epilepticus. Epilepsy Res. 2018 08; 144:1-6. View Abstract

  108. Different as night and day: Patterns of isolated seizures, clusters, and status epilepticus. Epilepsia. 2018 05; 59(5):e73-e77. View Abstract

  109. Towards acute pediatric status epilepticus intervention teams: Do we need "Seizure Codes"? Seizure. 2018 May; 58:133-140. View Abstract

  110. Factors associated with treatment delays in pediatric refractory convulsive status epilepticus. Neurology. 2018 05 08; 90(19):e1692-e1701. View Abstract

  111. Association of Time to Treatment With Short-term Outcomes for Pediatric Patients With Refractory Convulsive Status Epilepticus. JAMA Neurol. 2018 04 01; 75(4):410-418. View Abstract

  112. Comparative Effectiveness of Levetiracetam vs Phenobarbital for Infantile Epilepsy. JAMA Pediatr. 2018 04 01; 172(4):352-360. View Abstract

  113. Common data elements for epilepsy mobile health systems. Epilepsia. 2018 05; 59(5):1020-1026. View Abstract

  114. Can a collaborative healthcare network improve the care of people with epilepsy? Epilepsy Behav. 2018 05; 82:189-193. View Abstract

  115. Conscious control of breathing: A key to prevention of sudden unexpected death in epilepsy? Ann Neurol. 2018 03; 83(3):449-450. View Abstract

  116. Why West? Comparisons of clinical, genetic and molecular features of infants with and without spasms. PLoS One. 2018; 13(3):e0193599. View Abstract

  117. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives. Epilepsia. 2018 04; 59(4):745-752. View Abstract

  118. Patterns of epileptic seizure occurrence. Brain Res. 2019 01 15; 1703:3-12. View Abstract

  119. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia. 2018 04; 59(4):739-744. View Abstract

  120. Should patients with complex febrile seizure be admitted for further management? Am J Emerg Med. 2018 08; 36(8):1386-1390. View Abstract

  121. Devices for Ambulatory Monitoring of Sleep-Associated Disorders in Children with Neurological Diseases. Children (Basel). 2017 Dec 25; 5(1). View Abstract

  122. The Need for Antiepileptic Drug Chronotherapy to Treat Selected Childhood Epilepsy Syndromes and Avert the Harmful Consequences of Drug Resistance. J Cent Nerv Syst Dis. 2017; 9:1179573516685883. View Abstract

  123. New-Onset Status Epilepticus in Pediatric Patients: Causes, Characteristics, and Outcomes. Pediatr Neurol. 2018 03; 80:61-69. View Abstract

  124. Sleep patterns predictive of daytime challenging behavior in individuals with low-functioning autism. Autism Res. 2018 02; 11(2):391-403. View Abstract

  125. Response to clobazam in continuous spike-wave during sleep. Dev Med Child Neurol. 2018 03; 60(3):283-289. View Abstract

  126. Time to continuous electroencephalogram in repeated admissions to the pediatric intensive care unit. Seizure. 2018 Jan; 54:19-26. View Abstract

  127. The impact of hypsarrhythmia on infantile spasms treatment response: Observational cohort study from the National Infantile Spasms Consortium. Epilepsia. 2017 12; 58(12):2098-2103. View Abstract

  128. Behaviorally-determined sleep phenotypes are robustly associated with adaptive functioning in individuals with low functioning autism. Sci Rep. 2017 10 27; 7(1):14228. View Abstract

  129. Rescue Medications in Epilepsy Patients: A Family Perspective. Seizure. 2017 Nov; 52:188-194. View Abstract

  130. Multicenter clinical assessment of improved wearable multimodal convulsive seizure detectors. Epilepsia. 2017 11; 58(11):1870-1879. View Abstract

  131. Early-Life Epilepsies and the Emerging Role of Genetic Testing. JAMA Pediatr. 2017 09 01; 171(9):863-871. View Abstract

  132. Continuous EEG in Pediatric Critical Care: Yield and Efficiency of Seizure Detection. J Clin Neurophysiol. 2017 Sep; 34(5):421-426. View Abstract

  133. Novel clinical manifestations in patients with KCNA2 mutations. Seizure. 2017 Oct; 51:74-76. View Abstract

  134. Disparities in epilepsy surgery in the United States of America. J Neurol. 2017 Aug; 264(8):1735-1745. View Abstract

  135. Effect of vigabatrin on seizure control and safety profile in different subgroups of children with epilepsy. Epilepsia. 2017 09; 58(9):1575-1585. View Abstract

  136. Electrographic Seizures in Preterm Neonates in the Neonatal Intensive Care Unit. J Child Neurol. 2017 Sep; 32(10):880-885. View Abstract

  137. A Question Worth Asking. J Clin Neurophysiol. 2017 Jul; 34(4):392. View Abstract

  138. Initial Treatment for Nonsyndromic Early-Life Epilepsy: An Unexpected Consensus. Pediatr Neurol. 2017 Oct; 75:73-79. View Abstract

  139. Nonintravenous rescue medications for pediatric status epilepticus: A cost-effectiveness analysis. Epilepsia. 2017 08; 58(8):1349-1359. View Abstract

  140. Diagnostic and Therapeutic Management of a First Unprovoked Seizure in Children and Adolescents With a Focus on the Revised Diagnostic Criteria for Epilepsy. J Child Neurol. 2017 07; 32(8):774-788. View Abstract

  141. Use of EEG in critically ill children and neonates in the United States of America. J Neurol. 2017 Jun; 264(6):1165-1173. View Abstract

  142. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. Brain. 2017 May 01; 140(5):1316-1336. View Abstract

  143. Increasing Ketamine Use for Refractory Status Epilepticus in US Pediatric Hospitals. J Child Neurol. 2017 06; 32(7):638-646. View Abstract

  144. Genetics and genotype-phenotype correlations in early onset epileptic encephalopathy with burst suppression. Ann Neurol. 2017 Mar; 81(3):419-429. View Abstract

  145. Understanding Death in Children With Epilepsy. Pediatr Neurol. 2017 05; 70:7-15. View Abstract

  146. Time to electroencephalography is independently associated with outcome in critically ill neonates and children. Epilepsia. 2017 03; 58(3):420-428. View Abstract

  147. Reduced thalamic volume in patients with Electrical Status Epilepticus in Sleep. Epilepsy Res. 2017 02; 130:74-80. View Abstract

  148. Refractory status epilepticus in children with and without prior epilepsy or status epilepticus. Neurology. 2017 Jan 24; 88(4):386-394. View Abstract

  149. Seizures caused by brain tumors in children. Seizure. 2017 Jan; 44:98-107. View Abstract

  150. Texting Rhythm With Temporal Predominance. J Clin Neurophysiol. 2016 Dec; 33(6):570. View Abstract

  151. Refractory Status Epilepticus in Children: Intention to Treat With Continuous Infusions of Midazolam and Pentobarbital. Pediatr Crit Care Med. 2016 10; 17(10):968-975. View Abstract

  152. Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort. Epilepsia. 2016 11; 57(11):1834-1842. View Abstract

  153. Interictal epileptiform discharges and cognition. Dev Med Child Neurol. 2017 01; 59(1):13-14. View Abstract

  154. HHV-6 and seizure: A systematic review and meta-analysis. J Med Virol. 2017 01; 89(1):161-169. View Abstract

  155. The future of medicine will be dark without international collaboration [corrected]. Seizure. 2016 10; 41:42. View Abstract

  156. Automated seizure detection systems and their effectiveness for each type of seizure. Seizure. 2016 Aug; 40:88-101. View Abstract

  157. Real-time multi-channel monitoring of burst-suppression using neural network technology during pediatric status epilepticus treatment. Clin Neurophysiol. 2016 08; 127(8):2820-2831. View Abstract

  158. Clobazam higher-evening differential dosing as an add-on therapy in refractory epilepsy. Seizure. 2016 Aug; 40:1-6. View Abstract

  159. 2014 Epilepsy Benchmarks Area III: Improve Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects. Epilepsy Curr. 2016 May-Jun; 16(3):192-7. View Abstract

  160. Effectiveness of once-daily high-dose ACTH for infantile spasms. Epilepsy Behav. 2016 06; 59:4-8. View Abstract

  161. Development and Feasibility Testing of a Critical Care EEG Monitoring Database for Standardized Clinical Reporting and Multicenter Collaborative Research. J Clin Neurophysiol. 2016 Apr; 33(2):133-40. View Abstract

  162. Response to treatment in a prospective national infantile spasms cohort. Ann Neurol. 2016 Mar; 79(3):475-84. View Abstract

  163. Effectiveness of antiepileptic therapy in patients with PCDH19 mutations. Seizure. 2016 Feb; 35:106-10. View Abstract

  164. Yield of emergent neuroimaging in children with new-onset seizure and status epilepticus. Seizure. 2016 Feb; 35:4-10. View Abstract

  165. aEEG and cEEG: Two complementary techniques to assess seizures and encephalopathy in neonates: Editorial on "Amplitude-integrated EEG for detection of neonatal seizures: A systematic review" by Rakshasbhuvankar et al. Seizure. 2015 Dec; 33:88-9. View Abstract

  166. Utility of initial EEG in first complex febrile seizure. Epilepsy Behav. 2015 Nov; 52(Pt A):200-4. View Abstract

  167. Treatment of electrical status epilepticus in sleep: A pooled analysis of 575 cases. Epilepsia. 2015 Nov; 56(11):1738-46. View Abstract

  168. Incidence, risk factors, and longitudinal outcome of seizures in long-term survivors of pediatric brain tumors. Epilepsia. 2015 Oct; 56(10):1599-604. View Abstract

  169. Should epileptiform discharges be treated? Epilepsia. 2015 Oct; 56(10):1492-504. View Abstract

  170. Outcomes in pediatric patients with nonconvulsive status epilepticus. Epilepsy Behav. 2015 Aug; 49:98-103. View Abstract

  171. Acute seizure suppression by transcranial direct current stimulation in rats. Ann Clin Transl Neurol. 2015 Aug; 2(8):843-56. View Abstract

  172. Autonomic changes following generalized tonic clonic seizures: An analysis of adult and pediatric patients with epilepsy. Epilepsy Res. 2015 Sep; 115:113-8. View Abstract

  173. Seizures and brain regulatory systems: consciousness, sleep, and autonomic systems. J Clin Neurophysiol. 2015 Jun; 32(3):188-93. View Abstract

  174. Time from convulsive status epilepticus onset to anticonvulsant administration in children. Neurology. 2015 Jun 09; 84(23):2304-11. View Abstract

  175. Therapeutic choices in convulsive status epilepticus. Expert Opin Pharmacother. 2015 Mar; 16(4):487-500. View Abstract

  176. Pediatric refractory epilepsy: A decision analysis comparing medical versus surgical treatment. Epilepsia. 2015 Feb; 56(2):263-72. View Abstract

  177. Autonomic changes in psychogenic nonepileptic seizures: toward a potential diagnostic biomarker? Clin EEG Neurosci. 2015 Jan; 46(1):16-25. View Abstract

  178. Clinical and Neuroimaging Profile of Children with Lesions in the Corpus Callosum. J Neuroimaging. 2015 Sep-Oct; 25(5):824-31. View Abstract

  179. Pediatric status epilepticus management. Curr Opin Pediatr. 2014 Dec; 26(6):668-74. View Abstract

  180. Febrile status epilepticus: time is of the essence. Epilepsy Curr. 2014 Nov-Dec; 14(6):345-7. View Abstract

  181. Development and validation of a seizure prediction model in critically ill children. Seizure. 2015 Feb; 25:104-11. View Abstract

  182. Passive fMRI mapping of language function for pediatric epilepsy surgical planning: validation using Wada, ECS, and FMAER. Epilepsy Res. 2014 Dec; 108(10):1874-88. View Abstract

  183. Subunit composition of neurotransmitter receptors in the immature and in the epileptic brain. Biomed Res Int. 2014; 2014:301950. View Abstract

  184. Seizure detection, seizure prediction, and closed-loop warning systems in epilepsy. Epilepsy Behav. 2014 Aug; 37:291-307. View Abstract

  185. Localization of sleep spindles, k-complexes, and vertex waves with subdural electrodes in children. J Clin Neurophysiol. 2014 Aug; 31(4):367-74. View Abstract

  186. Safety and retention rate of rufinamide in 300 patients: a single pediatric epilepsy center experience. Epilepsia. 2014 Aug; 55(8):1235-44. View Abstract

  187. Management of pediatric status epilepticus. Curr Treat Options Neurol. 2014 Jul; 16(7):301. View Abstract

  188. Comparison of pediatric patients with status epilepticus lasting 5-29 min versus =30 min. Epilepsy Behav. 2014 Aug; 37:1-6. View Abstract

  189. Copy number variation plays an important role in clinical epilepsy. Ann Neurol. 2014 Jun; 75(6):943-58. View Abstract

  190. Treatment for continuous spikes and waves during sleep (CSWS): survey on treatment choices in North America. Epilepsia. 2014 Jul; 55(7):1099-108. View Abstract

  191. Comparison of risk factors for pediatric convulsive status epilepticus when defined as seizures = 5 min versus seizures = 30 min. Seizure. 2014 Oct; 23(9):692-8. View Abstract

  192. Pediatric status epilepticus: how common is cerebrospinal fluid pleocytosis in the absence of infection? Seizure. 2014 Aug; 23(7):573-5. View Abstract

  193. Predicting diurnal and sleep/wake seizure patterns in paediatric patients of different ages. Epileptic Disord. 2014 Mar; 16(1):56-66. View Abstract

  194. Subunit composition of glutamate and gamma-aminobutyric acid receptors in status epilepticus. Epilepsy Res. 2014 May; 108(4):605-15. View Abstract

  195. Clobazam: effect on frequency of seizures and safety profile in different subgroups of children with epilepsy. Pediatr Neurol. 2014 Jul; 51(1):60-6. View Abstract

  196. Development and implementation of a quality improvement curriculum for child neurology residents: lessons learned. Pediatr Neurol. 2014 May; 50(5):452-7. View Abstract

  197. Diagnostic delays in children with early onset epilepsy: impact, reasons, and opportunities to improve care. Epilepsia. 2014 Jan; 55(1):123-32. View Abstract

  198. Electrocorticography for seizure foci mapping in epilepsy surgery. J Clin Neurophysiol. 2013 Dec; 30(6):554-70. View Abstract

  199. Electrographic seizures after convulsive status epilepticus in children and young adults: a retrospective multicenter study. J Pediatr. 2014 Feb; 164(2):339-46.e1-2. View Abstract

  200. Outcomes of vagal nerve stimulation in a pediatric population: a single center experience. Seizure. 2014 Feb; 23(2):105-11. View Abstract

  201. Gaps and opportunities in refractory status epilepticus research in children: a multi-center approach by the Pediatric Status Epilepticus Research Group (pSERG). Seizure. 2014 Feb; 23(2):87-97. View Abstract

  202. Long-term response to high-dose diazepam treatment in continuous spikes and waves during sleep. Pediatr Neurol. 2013 Sep; 49(3):163-170.e4. View Abstract

  203. Clinical application and evaluation of the Bien diagnostic criteria for Rasmussen encephalitis. Epilepsia. 2013 Oct; 54(10):1753-60. View Abstract

  204. The diagnostic yield of pediatric polysomnography based on the professional background of referring physicians. Clin Pediatr (Phila). 2013 Dec; 52(12):1154-60. View Abstract

  205. Priorities in pediatric epilepsy research: improving children's futures today. Neurology. 2013 Sep 24; 81(13):1166-75. View Abstract

  206. Continuous Spikes and Waves during Sleep: Electroclinical Presentation and Suggestions for Management. Epilepsy Res Treat. 2013; 2013:583531. View Abstract

  207. Electroencephalography monitoring in critically ill children: current practice and implications for future study design. Epilepsia. 2013 Aug; 54(8):1419-27. View Abstract

  208. Electrode localization for planning surgical resection of the epileptogenic zone in pediatric epilepsy. Int J Comput Assist Radiol Surg. 2014 Jan; 9(1):91-105. View Abstract

  209. Electrographic seizures in pediatric ICU patients: cohort study of risk factors and mortality. Neurology. 2013 Jul 23; 81(4):383-91. View Abstract

  210. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia. 2013 Aug; 54(8):1498-503. View Abstract

  211. Visual aids to medical data and computational diagnostics: new frontiers in pediatric neurology. Epilepsy Behav. 2013 Aug; 28(2):258-60. View Abstract

  212. Management of childhood epilepsy. Continuum (Minneap Minn). 2013 Jun; 19(3 Epilepsy):656-81. View Abstract

  213. Predictors of seizure occurrence in children undergoing pre-surgical monitoring. Seizure. 2013 Oct; 22(8):640-6. View Abstract

  214. Electroencephalography in the pediatric emergency department: when is it most useful? J Child Neurol. 2014 Apr; 29(4):475-82. View Abstract

  215. Clinical practice guidelines and practice parameters for the child neurologist. J Child Neurol. 2013 Jul; 28(7):917-25. View Abstract

  216. Cardiopulmonary complications during pediatric seizures: a prelude to understanding SUDEP. Epilepsia. 2013 Jun; 54(6):1083-91. View Abstract

  217. Chronopharmacology of anti-convulsive therapy. Curr Neurol Neurosci Rep. 2013 Apr; 13(4):339. View Abstract

  218. Pediatric ICU EEG monitoring: current resources and practice in the United States and Canada. J Clin Neurophysiol. 2013 Apr; 30(2):156-60. View Abstract

  219. Should readmission within 30 days after discharge of children hospitalized for a neurologic disorder be considered a quality assurance failure? J Child Neurol. 2013 Jun; 28(6):758-61. View Abstract

  220. Electroencephalographic monitoring in the pediatric intensive care unit. Curr Neurol Neurosci Rep. 2013 Mar; 13(3):330. View Abstract

  221. Sturge-Weber syndrome: clinical and radiological correlates in 86 patients. Ideggyogy Sz. 2013 Jan 30; 66(1-2):53-7. View Abstract

  222. Automated quantification of spikes. Epilepsy Behav. 2013 Feb; 26(2):143-52. View Abstract

  223. Electrical status epilepticus in sleep: clinical presentation and pathophysiology. Pediatr Neurol. 2012 Dec; 47(6):390-410. View Abstract

  224. The tower of Babel: survey on concepts and terminology in electrical status epilepticus in sleep and continuous spikes and waves during sleep in North America. Epilepsia. 2013 Apr; 54(4):741-50. View Abstract

  225. Risk factors associated with death in in-hospital pediatric convulsive status epilepticus. PLoS One. 2012; 7(10):e47474. View Abstract

  226. Clinical evolution of seizures: distribution across time of day and sleep/wakefulness cycle. J Neurol. 2013 Feb; 260(2):549-57. View Abstract

  227. Pediatric focal epilepsy syndromes. J Clin Neurophysiol. 2012 Oct; 29(5):425-40. View Abstract

  228. Dacrystic seizures: demographic, semiologic, and etiologic insights from a multicenter study in long-term video-EEG monitoring units. Epilepsia. 2012 Oct; 53(10):1810-9. View Abstract

  229. Overcoming barriers to successful epilepsy management. Epilepsy Curr. 2012 Jul; 12(4):158-60. View Abstract

  230. Chrono-epileptology: time to reconsider seizure timing. Seizure. 2012 Jul; 21(6):411. View Abstract

  231. Circadian patterns of generalized tonic-clonic evolutions in pediatric epilepsy patients. Seizure. 2012 Sep; 21(7):535-9. View Abstract

  232. Effect of treatment of obstructive sleep apnea on seizure outcomes in children with epilepsy. Pediatr Neurol. 2012 Jun; 46(6):359-62. View Abstract

  233. Diurnal and sleep/wake patterns of epileptic spasms in different age groups. Epilepsia. 2012 Jul; 53(7):1170-7. View Abstract

  234. Clinical staging and electroencephalographic evolution of continuous spikes and waves during sleep. Epilepsia. 2012 Jul; 53(7):1185-95. View Abstract

  235. Outcomes of epileptic spasms in patients aged less than 3 years: single-center United States experience. Pediatr Neurol. 2012 May; 46(5):276-80. View Abstract

  236. Short-term response of sleep-potentiated spiking to high-dose diazepam in electric status epilepticus during sleep. Pediatr Neurol. 2012 May; 46(5):312-8. View Abstract

  237. Early thalamic lesions in patients with sleep-potentiated epileptiform activity. Neurology. 2012 May 29; 78(22):1721-7. View Abstract

  238. Autonomic changes with seizures correlate with postictal EEG suppression. Neurology. 2012 Jun 05; 78(23):1868-76. View Abstract

  239. Patients with electrical status epilepticus in sleep share similar clinical features regardless of their focal or generalized sleep potentiation of epileptiform activity. J Child Neurol. 2013 Jan; 28(1):83-9. View Abstract

  240. Convulsive seizure detection using a wrist-worn electrodermal activity and accelerometry biosensor. Epilepsia. 2012 May; 53(5):e93-7. View Abstract

  241. Analysis of EEG patterns and genotypes in patients with Angelman syndrome. Epilepsy Behav. 2012 Mar; 23(3):261-5. View Abstract

  242. Behavioral measures and EEG monitoring using the Brain Symmetry Index during the Wada test in children. Epilepsy Behav. 2012 Mar; 23(3):247-53. View Abstract

  243. Epileptic syndromes with focal seizures of childhood and adolescence. Handb Clin Neurol. 2012; 107:195-208. View Abstract

  244. An electroencephalographic recording platform for real-time seizure detection. Annu Int Conf IEEE Eng Med Biol Soc. 2012; 2012:875-8. View Abstract

  245. Signal subspace integration for improved seizure localization. Annu Int Conf IEEE Eng Med Biol Soc. 2012; 2012:1016-9. View Abstract

  246. Treatment of pediatric status epilepticus. Curr Treat Options Neurol. 2011 Dec; 13(6):560-73. View Abstract

  247. Teaching NeuroImages: mesial temporal sclerosis after a prolonged unprovoked seizure in an infant. Neurology. 2011 Nov 08; 77(19):e112-3. View Abstract

  248. What is quality improvement and why should child neurologists care? J Child Neurol. 2012 Feb; 27(2):251-7. View Abstract

  249. Outcome of no resection after long-term subdural electroencephalography evaluation in children with epilepsy. J Neurosurg Pediatr. 2011 Sep; 8(3):269-78. View Abstract

  250. Selective serotonin reuptake inhibitors and periodic limb movements of sleep. Pediatr Neurol. 2011 Sep; 45(3):175-7. View Abstract

  251. Necrotizing granulomatous meningoencephalitis due to Balamuthia in an immunocompetent child. Neurology. 2011 Aug 23; 77(8):801-2. View Abstract

  252. Effect of continuous positive airway pressure treatment on seizure control in patients with obstructive sleep apnea and epilepsy. Epilepsia. 2011 Nov; 52(11):e168-71. View Abstract

  253. Sleep-wake patterns of seizures in children with lesional epilepsy. Pediatr Neurol. 2011 Aug; 45(2):109-13. View Abstract

  254. Experience with lacosamide in a series of children with drug-resistant focal epilepsy. Pediatr Neurol. 2011 Jun; 44(6):414-9. View Abstract

  255. Electroencephalogram monitoring during intracranial surgery for moyamoya disease. Pediatr Neurol. 2011 Jun; 44(6):427-32. View Abstract

  256. An empirical investigation of motion effects in eMRI of interictal epileptiform spikes. Magn Reson Imaging. 2011 Dec; 29(10):1401-9. View Abstract

  257. Localization of pediatric seizure semiology. Clin Neurophysiol. 2011 Oct; 122(10):1924-8. View Abstract

  258. Continuous spike and waves during sleep and electrical status epilepticus in sleep. J Clin Neurophysiol. 2011 Apr; 28(2):154-64. View Abstract

  259. Chronobiology of epilepsy: diagnostic and therapeutic implications of chrono-epileptology. J Clin Neurophysiol. 2011 Apr; 28(2):146-53. View Abstract

  260. Circadian distribution and sleep/wake patterns of generalized seizures in children. Epilepsia. 2011 Jun; 52(6):1076-83. View Abstract

  261. Can semiology predict psychogenic nonepileptic seizures? A prospective study. Ann Neurol. 2011 Jun; 69(6):997-1004. View Abstract

  262. Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases. Epileptic Disord. 2011 Mar; 13(1):18-21. View Abstract

  263. Rufinamide for the treatment of epileptic spasms. Epilepsy Behav. 2011 Feb; 20(2):344-8. View Abstract

  264. Circadian patterns of pediatric seizures. Neurology. 2011 Jan 11; 76(2):145-53. View Abstract

  265. Septo-optic dysplasia complicated by infantile spasms and bilateral choroidal fissure arachnoid cysts. J Neuroimaging. 2011 Jan; 21(1):89-91. View Abstract

  266. Higher evening antiepileptic drug dose for nocturnal and early-morning seizures. Epilepsy Behav. 2011 Feb; 20(2):334-7. View Abstract

  267. Incidence and clinical decision making for the Wada test over one decade: 1997-2007. Epileptic Disord. 2010 Dec; 12(4):249-54. View Abstract

  268. Experience with rufinamide in a pediatric population: a single center's experience. Pediatr Neurol. 2010 Sep; 43(3):155-8. View Abstract

  269. Surgical treatment of refractory status epilepticus in children: candidate selection and outcome. Semin Pediatr Neurol. 2010 Sep; 17(3):182-9. View Abstract

  270. Fears and promises of comparative effectiveness research. Acta Paediatr. 2010 Sep; 99(9):1311-3. View Abstract

  271. Clinical correlations of midline spikes in children. Epilepsy Behav. 2010 Aug; 18(4):460-5. View Abstract

  272. Crying with left temporal lobe seizures and Wada testing. Epilepsy Behav. 2010 Jul; 18(3):303-5. View Abstract

  273. Neuroimaging findings in children with benign focal epileptiform discharges. Epilepsy Res. 2010 Jun; 90(1-2):91-8. View Abstract

  274. Visual naming performance after ATL resection: impact of atypical language dominance. Neuropsychologia. 2010 Jun; 48(7):2221-5. View Abstract

  275. A self-administered screening instrument for psychogenic nonepileptic seizures. Neurology. 2010 Jan 19; 74(3):270; author reply 271. View Abstract

  276. Continuous monitoring of electrodermal activity during epileptic seizures using a wearable sensor. Annu Int Conf IEEE Eng Med Biol Soc. 2010; 2010:4415-8. View Abstract

  277. Childhood absence epilepsy in patients with benign focal epileptiform discharges. Pediatr Neurol. 2009 Dec; 41(6):428-34. View Abstract

  278. Language assessment in Wada test: comparison of methohexital and amobarbital. Seizure. 2009 Nov; 18(9):656-9. View Abstract

  279. Longer duration of epilepsy and earlier age at epilepsy onset correlate with impaired cognitive development in infancy. Epilepsy Behav. 2009 Nov; 16(3):431-5. View Abstract

  280. Memory performance is related to language dominance as determined by the intracarotid amobarbital procedure. Epilepsy Behav. 2009 Sep; 16(1):145-9. View Abstract

  281. Holocord spinal epidural abscess. J Child Neurol. 2009 Jun; 24(6):768-71. View Abstract

  282. A self-administered screening instrument for psychogenic nonepileptic seizures. Neurology. 2009 May 12; 72(19):1646-52. View Abstract

  283. Atypical language lateralization in epilepsy patients. Epilepsia. 2009 Jun; 50(6):1505-16. View Abstract

  284. Epilepsy surgery in children with electrical status epilepticus in sleep. Neurosurgery. 2009 Feb; 64(2):328-37; discussion 337. View Abstract

  285. Epilepsy surgery in epidermal nevus syndrome variant with hemimegalencephaly and intractable seizures. J Neurol. 2008 Nov; 255(11):1829-31. View Abstract

  286. Lateralizing value of epileptic nystagmus. Epilepsy Behav. 2008 Nov; 13(4):700-2. View Abstract

  287. Complications during the Wada test. Epilepsy Behav. 2008 Oct; 13(3):551-3. View Abstract

  288. Quo vadis Wada? Epilepsy Behav. 2008 Jul; 13(1):1-2. View Abstract

  289. Discontinuation of medications after successful epilepsy surgery in children. Pediatr Neurol. 2008 May; 38(5):340-4. View Abstract

  290. Pituitary stalk duplication in association with moya moya disease and bilateral morning glory disc anomaly - broadening the clinical spectrum of midline defects. J Neurol. 2008 Jun; 255(6):885-90. View Abstract

  291. Lateralization of interictal EEG findings. J Clin Neurophysiol. 2007 Oct; 24(5):379-85. View Abstract

  292. Risk factors for early visual deterioration in temporal arteritis. J Neurol Neurosurg Psychiatry. 2007 Nov; 78(11):1255-9. View Abstract

  293. Developmental outcome after epilepsy surgery in infancy. Pediatrics. 2007 May; 119(5):930-5. View Abstract

  294. Repeated intracarotid amobarbital tests. Epilepsia. 2007 Mar; 48(3):553-8. View Abstract

  295. Seizures during intracarotid methohexital and amobarbital testing. Epilepsy Behav. 2007 Feb; 10(1):49-54. View Abstract

  296. Index of suspicion. Pediatr Rev. 2006 Sep; 27(9):351-7. View Abstract

  297. [Suggestion for a new, patient-oriented epilepsy classification]. Nervenarzt. 2006 Aug; 77(8):961-9. View Abstract

  298. Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy. Seizure. 2006 Oct; 15(7):491-503. View Abstract

  299. Double-blind, randomized controlled study of bilateral cerebellar stimulation. Epilepsia. 2006 Jul; 47(7):1247; author reply 1248-9. View Abstract

  300. Intracranial lipomas and epilepsy. J Neurol. 2006 May; 253(5):590-3. View Abstract

  301. Are epilepsy classifications based on epileptic syndromes and seizure types outdated? Epileptic Disord. 2006 Mar; 8(1):81-5. View Abstract

  302. A proposal for a five-dimensional patient-oriented epilepsy classification. Epileptic Disord. 2005 Dec; 7(4):308-16. View Abstract

  303. The prognostic value of [F]FDG-PET in nonrefractory partial epilepsy. Epilepsia. 2005 Oct; 46(10):1654-60. View Abstract

  304. Lateralizing signs during seizures in focal epilepsy. Epilepsy Behav. 2005 Aug; 7(1):1-17. View Abstract

  305. Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen. Neurology. 2005 Mar 22; 64(6):1086-7. View Abstract

  306. Acute repetitive pilomotor seizures. Clin Neurophysiol. 2005 Apr; 116(4):989-90; author reply 990. View Abstract

  307. Mononeuropathy of the laryngeal recurrent nerve as possible manifestation of human immunodeficiency virus infection. Otolaryngol Head Neck Surg. 2004 Oct; 131(4):556-7. View Abstract

  308. Temporal arteritis. 1932. Arch Neurol. 2004 Oct; 61(10):1620-2. View Abstract

  309. Validity of language lateralisation by unilateral intracarotid Wada test. J Neurol Neurosurg Psychiatry. 2004 Sep; 75(9):1367; author reply 1367-8. View Abstract

  310. Lateralizing signs during seizures in infants. J Neurol. 2004 Sep; 251(9):1075-9. View Abstract

  311. Localising and lateralising value of ictal piloerection. J Neurol Neurosurg Psychiatry. 2004 Jun; 75(6):879-83. View Abstract

  312. Non-epileptic seizures of the elderly. J Neurol. 2004 Jun; 251(6):704-9. View Abstract

  313. Seizure semiology in the elderly: a video analysis. Epilepsia. 2004 Mar; 45(3):263-7. View Abstract

  314. Specific epileptic syndromes are rare even in tertiary epilepsy centers: a patient-oriented approach to epilepsy classification. Epilepsia. 2004 Mar; 45(3):268-75. View Abstract

  315. Aphasia after hemispherectomy in an adult with early onset epilepsy and hemiplegia. J Neurol Neurosurg Psychiatry. 2004 Jan; 75(1):149-51. View Abstract

  316. Stool-withholding activity mimicking epilepsy. Neurology. 2003 Nov 25; 61(10):1454-5. View Abstract

  317. Ictal spitting: clinical and electroencephalographic features. Epilepsia. 2003 Aug; 44(8):1064-9. View Abstract

  318. [Electric brain stimulation for epilepsy therapy]. Nervenarzt. 2003 Aug; 74(8):664-76. View Abstract

  319. Epileptic monocular nystagmus. Neurology. 2003 Jul 08; 61(1):145-7; author reply 147. View Abstract

  320. Late language transfer in patients with Rasmussen encephalitis. Epilepsia. 2003 Jun; 44(6):870-1. View Abstract

  321. Effects of subthalamic nucleus (STN) stimulation on motor cortex excitability. Neurology. 2003 Mar 11; 60(5):885-6; author reply 885-6. View Abstract

  322. Ictal urinary urge: further evidence for lateralization to the nondominant hemisphere. Epilepsia. 2003 Jan; 44(1):124-6. View Abstract

  323. Carotid artery dissection after the intracarotid amobarbital test. Neurology. 2002 Dec 10; 59(11):1797-8. View Abstract

  324. Neurological manifestations of the oculodentodigital dysplasia syndrome. J Neurol. 2002 May; 249(5):584-95. View Abstract

  325. Deep brain stimulation in epilepsy. J Clin Neurophysiol. 2001 Nov; 18(6):514-32. View Abstract

  326. [Experience with tiagabine in the clinical practice; new insights as to the efficacy and safety profile]. Nervenarzt. 2001 Oct; 72(10):764-9. View Abstract

Education

Medical School

University of Massachusetts Medical School

Worcester, MA

Residency

Warren Alpert Medical School

Providence, RI

Education

Medical School

New York University School of Medicine

1992, New York, NY

Internship

New York University School of Medicine/Bellvue Hospital

1993, New York, NY

Residency

New York University School of Medicine

1996, New York, NY

Fellowship

Boston Children's Hospital

1999, Boston, MA

Publications

Education

Medical School

University of Southern California

Los Angeles, CA

Residency

UCLA Center for Health Sciences

Los Angeles, CA

Education

Undergraduate School

Princeton University

Princeton, NJ

Graduate School

Philadelphia College of Osteopathic Medicine

Philadelphia, PA

Medical School

Drexel University College of Medicine

Philadelphia, PA

Residency

Pediatrics

St. Christopher's Hospital for Children

Philadelphia, PA

Fellowship

Neonatal-Perinatal Medicine

St. Christopher's Hospital for Children

Philadelphia, PA

Education

Undergraduate School

SUNY Albany

Albany, NY

Medical School

Albert Einstein College of Medicine

Bronx, NY

Residency

Albert Einstein/Montefiore Medical Centers

Bronx, NY

Fellowship

Mount Sinai School of Medicine

New York, NY

Education

Undergraduate School

Cornell University

Ithaca, NY

Medical School

Downstate Medical School

Brooklyn, NY
Subscribe to English

Talk to Lesley

If this is a medical emergency, please dial 9-1-1. This application should not be used in an emergency. This chat is being transmitted via a secure connection.

Hi! My name is Lesley. I am a virtual agent programmed to help you. If you would like to speak to a live agent, please call 617-355-6000.

For questions regarding an appointment, doctor notes, or specific questions related to symptoms/diagnosis, please call the department of clinic directly.

Quick links:

- MyChildrens Portal
- Global Services
- Find a Doctor
- Find a Location
- Programs and Services